Silo Pharma(SILO)
$1.84+0.05 (+2.91%)
SILO
Silo Pharma financials statements
$1.84
At close:+0.05 (+2.91%)
Silo Pharma (SILO) Ratios
225 Followers
Silo Pharma Ratios
SILO's free cash flow for Q2 2026 was $-781.86K. For the 2026 fiscal year, SILO's free cash flow was increased by $0.00 and operating cash flow was $-781.86K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 11.36 | 4.29 | 9.90 | 26.52 | 21.23 |
| Quick Ratio | 11.36 | 4.29 | 9.90 | 26.52 | 21.23 |
| Cash Ratio | 7.30 | 2.36 | 4.54 | 26.05 | 20.07 |
| Solvency Ratio | -3.24 | -1.85 | -2.36 | -3.00 | 2.73 |
| Operating Cash Flow Ratio | -7.17 | -2.32 | -4.16 | -8.02 | -4.65 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ 6.09M | $ 4.73M | $ 6.11M | $ 10.27M | $ 8.97M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.21 | 1.47 | 1.25 | 1.13 | 1.16 |
| Debt Service Coverage Ratio | -112.03 | -861.84 | -744.76 | -1775.89 | 1370.27 |
| Interest Coverage Ratio | -114.76 | -925.59 | -791.87 | -1649.68 | -903.93 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.07 | 0.02 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 1.14 | 0.89 | 0.97 | 2.91 | -2.35 |
| Profitability Margins | |||||
| Gross Profit Margin | -1128.89% | 91.90% | 91.90% | 91.90% | 92.98% |
| EBIT Margin | -5811.76% | -6085.54% | -5029.28% | -5416.20% | 5872.56% |
| EBITDA Margin | -5795.89% | -6076.96% | -5029.28% | -5416.20% | 5872.56% |
| Operating Profit Margin | -5936.95% | -6526.44% | -5347.41% | -5031.28% | -3850.95% |
| Pretax Profit Margin | -5863.50% | -6092.59% | -5036.04% | -5419.25% | 5868.30% |
| Net Profit Margin | -5863.50% | -6092.59% | -5132.57% | -5420.86% | 5477.86% |
| Continuous Operations Profit Margin | -5863.50% | -6092.59% | -5036.04% | -5419.25% | 5833.39% |
| Net Income Per EBT | 100.00% | 100.00% | 101.92% | 100.03% | 93.35% |
| EBT Per EBIT | 98.76% | 93.35% | 94.18% | 107.71% | -152.39% |
| Return on Assets (ROA) | -55.59% | -59.27% | -47.77% | -33.57% | 37.21% |
| Return on Equity (ROE) | -67.05% | -87.26% | -59.91% | -37.80% | 43.08% |
| Return on Capital Employed (ROCE) | -61.55% | -81.76% | -55.31% | -32.37% | -27.44% |
| Return on Invested Capital (ROIC) | -61.55% | -81.76% | -55.31% | -32.37% | -27.28% |
| Return on Tangible Assets | -57.23% | -61.26% | -47.77% | -33.57% | 37.21% |
| Earnings Yield | -148.34% | -134.11% | -83.44% | -50.93% | 1438.82% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 1.09 | 0.00 |
| Payables Turnover | 1.53 | 0.00 | 0.01 | 0.02 | 0.01 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Working Capital Turnover Ratio | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Cash Conversion Cycle | -238.13 | -99027.35 | -43983.06 | -22437.14 | -30485.01 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 334.16 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 238.13 | 99027.35 | 43983.06 | 22771.30 | 30485.01 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | 334.16 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -8.34 | -15.63 | -1.05 | -1.53 | -1.20 |
| Free Cash Flow Per Share | -8.34 | -15.63 | -1.05 | -1.53 | -1.20 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -569504.00 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | -569504.00 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | -64.65 | -53.17 | -44.72 | -48.51 | -31.97 |
| Free Cash Flow Yield | -163.56% | -117.05% | -72.71% | -45.57% | -839.62% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.68 | -0.75 | -1.20 | -1.96 | 0.07 |
| Price-to-Sales (P/S) Ratio | 39.53 | 45.43 | 61.51 | 106.45 | 3.81 |
| Price-to-Book (P/B) Ratio | 0.45 | 0.65 | 0.72 | 0.74 | 0.03 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.61 | -0.85 | -1.38 | -2.19 | -0.12 |
| Price-to-Operating Cash Flow Ratio | -0.61 | -0.85 | -1.38 | -2.19 | -0.12 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | 0.90 | 0.04 | 0.01 | -0.00 |
| Enterprise Value Multiple | 0.45 | 0.14 | -0.25 | 0.95 | -2.29 |
| Enterprise Value | -1.90M | -630.25K | 910.71K | -3.69M | -9.57M |
| EV to EBITDA | 0.45 | 0.14 | -0.25 | 0.95 | -2.29 |
| EV to Sales | -26.33 | -8.74 | 12.63 | -51.21 | -134.23 |
| EV to Free Cash Flow | 0.41 | 0.16 | -0.28 | 1.06 | 4.20 |
| EV to Operating Cash Flow | 0.41 | 0.16 | -0.28 | 1.06 | 4.20 |
| Tangible Book Value Per Share | 10.89 | 19.53 | 2.01 | 4.53 | 4.78 |
| Shareholders’ Equity Per Share | 11.28 | 20.52 | 2.01 | 4.53 | 4.78 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Revenue Per Share | 0.13 | 0.29 | 0.02 | 0.03 | 0.04 |
| Net Income Per Share | -7.57 | -17.90 | -1.20 | -1.71 | 2.06 |
| Tax Burden | 1.00 | 1.00 | 1.02 | 1.00 | 0.93 |
| Interest Burden | 1.01 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 29.97 | 32.84 | 11.72 | 17.84 | 9.74 |
| SG&A to Revenue | 29.79 | 33.34 | 42.67 | 33.67 | 31.79 |
| Stock-Based Compensation to Revenue | 1.62 | 0.00 | 0.20 | 2.16 | 0.00 |
| Income Quality | 1.10 | 0.87 | 0.87 | 0.89 | -0.55 |
Currency in USD
